Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-002284

Chief Commercial Officer acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Marshak Richard Chief Commercial Officer 2025-01-27 Grant or award +12,500 46,626 D
Derivatives
Marshak Richard Chief Commercial Officer 2025-01-27 Grant or award · Employee Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X05/form4-01292025_100134.xml…